Walleye Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Sell
4,800
-35,700
-88% -$7.69M ﹤0.01% 2061
2025
Q4
$8.32M Sell
40,500
-19,900
-33% -$3.75M 0.03% 773
2025
Q3
$9.48M Buy
60,400
+14,600
+32% +$2.26M 0.04% 575
2025
Q2
$7.69M Buy
45,800
+18,300
+67% +$2.72M 0.03% 627
2025
Q1
$3.79M Buy
27,500
+9,500
+53% +$1.21M 0.02% 967
2024
Q4
$2.13M Sell
18,000
-21,500
-54% -$2.51M 0.01% 1732
2024
Q3
$4.37M Buy
39,500
+3,500
+10% +$366K 0.01% 1273
2024
Q2
$3.54M Sell
36,000
-30,400
-46% -$3.1M 0.01% 1570
2024
Q1
$7.43M Sell
66,400
-64,700
-49% -$6.98M 0.01% 1028
2023
Q4
$13.2M Buy
131,100
+56,000
+75% +$5.56M 0.03% 538
2023
Q3
$6.52M Sell
75,100
-2,400
-3% -$217K 0.02% 855
2023
Q2
$7.33M Buy
77,500
+75,400
+3,590% +$6.37M 0.03% 540
2023
Q1
$159K Sell
2,100
-13,000
-86% -$981K ﹤0.01% 2648
2022
Q4
$1.16M Buy
15,100
+400
+3% +$30.4K 0.02% 903
2022
Q3
$980K Buy
+14,700
New +$932K 0.02% 986

Other funds holding CAH

Walleye Capital's CAH Position: Q1 2026 in Review

Walleye Capital reduced its Cardinal Health (CAH) stake by 97% in Q1 2026, selling an estimated $17M and leaving 2,410 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #2652.

Walleye Capital first reported a position in CAH in Q3 2018 and has held it in 16 quarters since. The position peaked at $38.8M in Q3 2025. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Walleye Capital held 2,410 shares of Cardinal Health worth $509K as of Q1 2026.
  • Walleye Capital sold 78,892 Cardinal Health shares in Q1 2026, an estimated $17M.
  • Cardinal Health made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2652 holding.
  • Walleye Capital first reported a position in Cardinal Health in Q3 2018 and has held it in 16 quarters since.
  • Walleye Capital's Cardinal Health position peaked at $38.8M in Q3 2025.
  • 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.